Genomics BioSci & Tech. Co.,Ltd.
4195.TWO
Price:
$24.7
Market Cap:
$1.79B
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening se...[Read more]
Industry
Biotechnology
IPO Date
2013-12-16
Stock Exchange
TWO
Ticker
4195.TWO
PE Ratio
[-21.48]
ROE
[-31.04%]
Current Ratio
[1.35]
Dividend Yield
[0%]
Enterprise Value
[2.26B]
Dividend History
The Current Ratio as of December 2025 (TTM) for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is 1.35
According to Genomics BioSci & Tech. Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.35. This represents a change of -41.83% compared to the average of 2.32 of the last 4 quarters.
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Historical Current Ratio (quarterly & annually)
How has 4195.TWO Current Ratio performed in the past?
The mean historical Current Ratio of Genomics BioSci & Tech. Co.,Ltd. over the last ten years is 2.90. The current 1.35 Current Ratio has changed 4.54% with respect to the historical average. Over the past ten years (40 quarters), 4195.TWO's Current Ratio was at its highest in in the June 2023 quarter at 4.21. The Current Ratio was at its lowest in in the June 2019 quarter at 0.
Average
2.90
Median
3.07
Minimum
1.61
Maximum
3.80
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Genomics BioSci & Tech. Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.35%
Maximum Annual Current Ratio = 3.80
Minimum Annual Increase = -50.24%
Minimum Annual Current Ratio = 1.61
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.61 | -50.24% |
| 2023 | 3.23 | 9.52% |
| 2022 | 2.95 | 10.77% |
| 2021 | 2.66 | -29.91% |
| 2020 | 3.80 | 19.35% |
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Average Current Ratio
How has 4195.TWO Current Ratio performed in the past?
The current Current Ratio of Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.60
5-year avg
2.85
10-year avg
2.90
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Current Ratio vs. Peers
How is 4195.TWO’s Current Ratio compared to its peers?
Genomics BioSci & Tech. Co.,Ltd.’s Current Ratio is greater than Sunny Pharmtech Inc. (1.30), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (3.34), less than Advagene Biopharma Co., Ltd. (30.83), less than Greenyn Biotechnology Co., Ltd (7.44), less than NaviFUS Corp. (12.72), less than Enimmune corporation (1.41), less than Meribank Biotech Co., Ltd (1.58), less than Hcmed (6.86), less than GeneReach Biotechnology Corp. (2.39), less than GlycoNex Incorporation (11.24),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.30 | $2.01B | |
| 3.34 | $1.91B | |
| 30.83 | $1.67B | |
| 7.44 | $2.01B | |
| 12.72 | $1.44B | |
| 1.41 | $1.48B | |
| 1.58 | $1.53B | |
| 6.86 | $2.41B | |
| 2.39 | $1.12B | |
| 11.24 | $2.69B |
Build a custom stock screener for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomics BioSci & Tech. Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Genomics BioSci & Tech. Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Genomics BioSci & Tech. Co.,Ltd.'s Current Ratio?
How is the Current Ratio calculated for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the highest Current Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 3-year average Current Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 5-year average Current Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
How does the current Current Ratio for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) compare to its historical average?